POLY MEDICURE LIMITED vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of POLY MEDICURE LIMITED (POLYMED) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads POLYMED vs ZYDUSLIFE on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

52.88
P/E ratio
22.83
5.66
P/B ratio
4.09
0.21%
Dividend yield
0.09%
₹31.78
EPS
₹50.09

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

11.20%
Return on equity
21.20%
14.00%
Return on capital
21.00%
24.00%
EBITDA margin
31.00%
17.12%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

18.92%
Revenue CAGR (3Y)
16.35%
21.49%
Profit CAGR (3Y)
34.80%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹17,033 Cr
Market cap
₹1.15L Cr
₹1,875 Cr
Revenue
₹27,148 Cr
₹321 Cr
Net profit
₹5,124 Cr
0.11
Debt / equity
0.46
POLY MEDICURE LIMITED
  • + ["Company has delivered good profit growth of 19.4% CAGR over last 5 years"]
  • ["Debtor days have increased from 83.8 to 103 days.", "Working capital days have increased from 126 days to 249 days"]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
POLY MEDICURE LIMITED full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

POLY MEDICURE LIMITED vs ZYDUS LIFESCIENCES LTD: Share Price, Valuation & Which to Buy | DocStoX